Sophia Zoungas's Publications

Zoungas S., Cooper M., Woodward Mark, Williams B., Hillis G., Li Q., Marre M., Thomas M., Pickering R., Chalmers J.
Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes
Journal Article
2015
Diabetes Care
Zoungas S., Navaneethan S., Kang A., Nigwekar S., Kulshrestha S., Strippoli G., Ninomiya T., Cass A., Gallagher M., Jardine M
Interventions for lowering plasma homocysteine levels in kidney transplant recipients
Journal Article
2015
Cochrane Database of Systematic Reviews
Zoungas S., Cooper M., Woodward Mark, Williams B., Hillis G., Li Q., Marre M., Thomas M., Pickering R., Chalmers J.
The Relationship Between Levels of Advanced Glycation End-Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes
Journal Article
2015
Diabetes Care
Cass Alan, Zoungas S., Jun M., Hirakawa Y., Hawley C., Toyama T., Pilmore H., Badve S., Lo C, Perkovic Vlado
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease (Protocol)
Journal Article
2015
Cochrane Database of Systematic Reviews
Zoungas Sophia, Curtis A, McNeil J, Tonkin A
Statins in the elderly: an answered question?
Journal Article
2014
Current Opinion in Cardiology
Arima Hisatomi, Zoungas S., Woodward Mark, Ninomiya T., Hirakawa Y, Cooper M, Hamet P, Mancia G, Poulter N, Harrap S
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial
Journal Article
2014
Diabetes Care
Zoungas Sophia, Curtis A., McNeil J., Tonkin A.
Treatment of dyslipidemia and cardiovascular outcomes: the journey so far--is this the end for statins?
Journal Article
2014
Clinical Pharmacology and Therapeutics
Hillis Graham, Woodward Mark, Zoungas Sophia, Blomster J., Poulter N., Williams B., Mancia G., Harrap S., Li Q., Chalmers J.
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes mellitus.
Journal Article
2014
Diabetes Care
Cooper M., Woodward Mark, Zoungas Sophia, Poulter N., Williams B., Hamet P., Harrap S., Li Q., Heller S., Marre M.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
Journal Article
2014
Diabetologia
Arima Hisatomi, Hirakawa Y., Woodward Mark, Zoungas Sophia, Poulter N., Williams B., Mancia G., Harrap S., Chalmers J., Patel Anushka
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial
Journal Article
2014
Hypertension
Arima Hisatomi, Monaghan H., Joshi Rohina, Zoungas Sophia, Hirakawa Y, Hamet P, Mancia G, Poulter N, Harrap S, Li Q
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Journal Article
2014
New England Journal of Medicine
Kerr P., Polkinghorne K., Teede H., Zoungas Sophia, Lo C., Lui M., Ranasinha S., Nathan D., Zheng H.
Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease
Journal Article
2014
Diabetes Research and Clinical Practice
Zoungas Sophia, Curtis A, McNeil J, Tonkin A
Treatment of dyslipidemias and cardiovascular outcomes: the journey so far. Is this the end for statins?
Journal Article
2014
Clinical Pharmacology and Therapeutics
Li Qiang, de Galan Bastiaan, Skulina C., Huxley Rachel, Woodward Mark, Zoungas Sophia, Batty G., Taylor B., Harrap S., Colagiuri S.
Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial
Journal Article
2013
European Psychiatry
van Dieren S., Fulcher G., Woodward Mark, Zoungas Sophia, Beulens J., Colagiuri S., Hamet P., Heller S., Williams B., Mancia G.
Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial
Journal Article
2013
Diabetes, Obesity and Metabolism
Li Qiang, Clarke P., Woodward Mark, Skulina C., Zoungas Sophia, Patel Anushka
The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetes
Journal Article
2013
Diabetic Medicine
Heerspink H., Li Qiang, Cass Alan, Woodward Mark, Zoungas Sophia, Marre M., Jun M., Poulter N., Hamet P., Mancia G.
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Journal Article
2013
Kidney International
Mooney J., Barzi Federica, Holzmann M., Welten G., Biancari F., Wu V., Ranasinghe Isuru, Cass Alan, Zoungas Sophia, Hillis Graham
Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: a systematic review and meta-analysis
Journal Article
2013
Anesthesiology
Morton J., Ng M., Woodward Mark, Zoungas Sophia, ADVANCE Collaborative Group Writing Committee, Marre M., Poulter N., Mancia G., Cooper M., Chalmers J.
The association of high density lipoprotein cholesterol with cancer incidence in type 2 diabetes: a case of reverse causality?
Journal Article
2013
Cancer Epidemiology Biomarkers & Prevention
Arima Hisatomi, Ninomiya T., Hata Jun, Fulcher G., Joshi Rohina, Kengne Andre, Woodward Mark, Zoungas Sophia, Watson J., Adams M.
Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial
Journal Article
2013
PLOS ONE

Sophia Zoungas's Publications

Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes

Interventions for lowering plasma homocysteine levels in kidney transplant recipients

The Relationship Between Levels of Advanced Glycation End-Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease (Protocol)

Statins in the elderly: an answered question?

Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial

Treatment of dyslipidemia and cardiovascular outcomes: the journey so far--is this the end for statins?

The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes mellitus.

Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes

Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease

Treatment of dyslipidemias and cardiovascular outcomes: the journey so far. Is this the end for statins?

Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial

Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial

The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetes

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes

Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: a systematic review and meta-analysis

The association of high density lipoprotein cholesterol with cancer incidence in type 2 diabetes: a case of reverse causality?

Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial

The George Institute for Global Health

The George Institute country sites:

Acknowledgement of Country